Genmab — November 2020
-
Fredagens aviser med Matas, Genmab og ALK-Abellõ
https://www.proinvestor.com/investornyt/669362/fredagens-aviser-med-matas-genmab-og-alk-abello -
Breakout og profit target 2600 inden for kommende 11 dage https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/88228_break_out.JPG
-
Genmab
@Genmab
·
1 t
Join us at 8:30 AM EST / 2:30 PM CET on Nov 13 for Capital Markets Day to hear more about our growing pipeline and capabilities. Register here: https://events.bizzabo.com/GenmabCMD -
Tror den lukker i 2500
-
Det var lige vel optimistisk. Nu skal weekenden nydes inden vi følger Genmab på vejen mod 2600 i næste uge -
som StockBull dikterer -
On Nov. 16, President and CEO Jan G. J. van de Winkel is sitting down with @clivecookson of @FT in a fireside chat at @ConsiliumHC Annual Healthcare Virtual Conference. There is still time to register to catch this insightful conversation. onlinexperiences.com/scripts/Server… https://twitter.com/genmab/status/1324774759897407490?s=12
-
Genmab er deleme nået langt når selv Financial Times anmoder Jan om et Fireside Chat
-
Lidt vedr. HALO og medikamenterne Apollo, Andromeda, Daratumumab:
-
-
HALO er jo steget som en raket siden regnskabet for nogle dage siden.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind